Related Experiment Video
Updated: Jun 27, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Developing stakeholder involvement for introducing public health genomics into public policy
1PHG Foundation, Strangeways Research Laboratory, Cambridge CB1 8RN, UK. hilary.burton@phgfoundation.org
Public Health Genomics
|November 22, 2008
Summary
Public health genomics (PHG) requires diverse stakeholder engagement. Addressing knowledge gaps is crucial for integrating PHG into policies effectively.
Area of Science:
- Public Health
- Genomics
- Social Sciences
Background:
- Public health genomics (PHG) integrates knowledge from natural and social sciences for policy and public outreach.
- Diverse stakeholders with varied backgrounds are essential for PHG initiatives.
- Significant knowledge gaps exist between scientists, the public, and professionals, complicating engagement.
Purpose of the Study:
- To explore public policy areas involving PHG.
- To establish principles for effective stakeholder involvement.
- To identify potential stakeholders for PHG policy integration.
Main Methods:
- Literature review and policy analysis.
- Stakeholder analysis and engagement principles.
- Case study considerations for PHG implementation.
Main Results:
- PHG impacts various public policy domains.
- Stakeholder engagement is fundamental but challenging due to knowledge disparities.
- A broad range of stakeholders must be considered for PHG integration.
Conclusions:
- Successful PHG integration into policy necessitates strategic stakeholder engagement.
- Tailoring engagement strategies to specific projects is critical.
- Bridging knowledge gaps is key to maximizing PHG's public health impact.
More Related Videos
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...